Market Research Reports: Asia Pacific Type 2 Diabetes Therapeutics Market to be Worth US$10.5 Billion by 2020

Share Article

The report provides deep insights into the markets in the Asia Pacific region in terms of type 2 diabetes. The report particularly focuses on the markets of Australia, China, Japan, and India.

The Asia Pacific type 2 diabetes therapeutics market was valued at an estimated US$6.5 billion. The market is expected to grow at a CAGR of 7.1% between 2013 and 2020, reaching an overall worth of US$10.5 billion at the end of the forecast period.

View Full Report at

The report credits this strong growth rate to the expected approval of multiple products in the upcoming classes of treatment. These classes include Sodium Glucose Transporter-2 (SGLT-2) inhibitors, and Glucagon-Like Peptide-1 (GLP-1) agonists.

Another factor that drives the Asia Pacific type 2 diabetes therapeutics market is the increasing populations in China and India.

The research report has been compiled through the information sourced from proprietary databases and primary and secondary research methods, coupled with a strong in house analysis that is performed by research experts.

Download Detail Report With Complete TOC at

Introductory passages in the report are related to a brief introduction to type 2 diabetes. This includes etiology, pathophysiology, and diagnosis methods. The report then delves into a detailed section that deals with the medical safety, efficacy, strengths and weaknesses, while also providing a heat map in the relevant comparisons.

The report offers estimates on the market size till the forecast period ends at 2020, along with major historical data until the year 2013. The report encompasses treatment algorithms, disease epidemiology, and treatment use patterns.

The report also provides a detailed look at the recent market changes, clinical trial failure rates, and an analysis of the pipeline molecules.

The report points to the innovations in the type 2 diabetes market and their impact on the Asia Pacific region. It then provides a competitive landscape that includes the most promising product pipelines in order for the user to gain an insight into their standing. The report also catches up with the latest trends in type 2 diabetes in terms of the size and duration of clinical trials and their comparison to the industry average.

Explore All GBI Market Research Reports at

Some of the key aspects of the Asia Pacific type 2 diabetes therapeutics market that are included in the report are the treatment usage patterns, pipeline analysis, market characterization, co-development deals and key licensing procedures in the four major APAC markets.

The report also discusses the multiple possibilities that could change the forecast data by accounting for market activities such as the introduction of new drugs, the changes in disease epidemiology, and the expiration of patents on key drugs.

About is the most comprehensive collection of market research reports, supporting clients’ market intelligence needs with over 100,000 market research reports, company profiles, data books, and regional market profits in its repository. We also offer consulting support for custom market research needs.

Our document database is updated by the hour, which means that our customers always have access to fresh data spanning over 300 industries. From Fortune 500 companies to SMEs, has built a veritable reputation for fulfilling the most exacting market research needs.


Toll Free: 866-997-4948
Email: sales(at)marketresearchreports(dot)biz

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michell Thoras

Sheela AK
Follow us on
Visit website